Article No
BPS-27003
CAS No | 763113-22-0 |
MW | 434.5 Da |
Additional Information | AZD2281, also known as Olaparib, is a poly(ADP-ribose) polymerase 1 (PARP1) inhibitor and an anti-cancer drug being tested in patients with mutations in the genes BRCA1 or BRCA2. |
Article No | BPS-27003 |
Country Availability | SE, FI, DK, NO, IS, EE, LV, LT |
Description | AZD2281 (Olaparib) |
Supplier | BPS Bioscience |
Format | White to off-white crystalline solid; granular or powder. |
Notes | AZD2281, also known as Olaparib, is a poly(ADP-ribose) polymerase 1 (PARP1) inhibitor and an anti-cancer drug being tested in patients with mutations in the genes BRCA1 or BRCA2. |
Molecular Formula | C24H23FN4O3 |
Alias Names | AZD-2281] [KU-59436 |
Product Type | Chemicals & Biochemicals |
Purity | ≥95% by HPLC |
Shipping Information | -20°C |
Size | 250 mg |
Solubility | Soluble in DMSO at 33 mg/ml; soluble in ethanol at 1.7 mg/ml with slight warming; very_x000D_ poorly soluble in water; maximum solubility in plain water is estimated to be about 10-20 µM buffers,_x000D_ serum, or other additives may increase or decrease the aqueous solubility. |
Storage | Store at or below -20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day. |
Technical Specifications | AZD2281, also known as Olaparib, is a poly(ADP-ribose) polymerase 1 (PARP1) inhibitor and an anti-cancer drug being tested in patients with mutations in the genes BRCA1 or BRCA2. |
Product Page Updated | 2024-01-09T13:23:45.900Z |